Skip to main content
PLX logo

PLX · Protalix BioTherapeutics, Inc.

Track PLX — free
$2.30 +0.08 (+3.60%)
Market Cap
$178.87M
Shares
80.57M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1006281 CUSIP 74365A309 13F (30d) 98 filings 96 filers Visit website Investor relations